Brady Corporation (BRC) Stock Price & How to Invest

Brady has been in business since 1914 and sells the things that tell people and machines what something is: safety and facility signage, product identification labels, wire markers, healthcare wristbands and identification badges, plus the printers, ribbons and specialty adhesive materials behind them. It runs on a geographic structure with two reportable segments, Americas & Asia (~$994 million of fiscal 2025 sales) and Europe & Australia (~$520 million). By product line, fiscal 2025 sales ran roughly ~$611 million in safety and facility identification, ~$429 million in product identification, ~$248 million in wire identification and ~$226 million across healthcare and people identification. The company employed ~6,400 people as of July 31, 2025 and spent ~$79.9 million on research and development that year, a little over ~5 percent of sales. A run of small acquisitions (Gravotech, AB&R and Microfluidic Solutions) had already pushed the product identification line up sharply before the Honeywell deal arrived.

The financial picture going into that deal was good. Trailing twelve month sales are ~$1.62 billion on ~$210 million of net income, or ~$4.37 of diluted earnings per share, and the fiscal third quarter ended April 30, 2026 produced sales of ~$435 million, up ~13.8 percent with organic growth of ~8.2 percent, alongside record adjusted diluted earnings per share of ~$1.50. Management raised full year adjusted earnings guidance to a range of ~$5.20 to ~$5.30 and named data center construction as one of the reasons demand improved. At ~$93 a share and a market value of ~$4.41 billion, BRC trades near ~21 times trailing earnings and closer to ~15 times what the market expects once Honeywell's Productivity Solutions and Services business (PSS) is in the numbers. That gap is the whole question. PSS generated ~$1.1 billion of sales in 2025 with ~3,000 employees, and Brady financed the purchase with ~$1.6 billion of new borrowings, turning a ~$149 million net cash position into real leverage for the first time in years.

The central risk is integration: PSS is a carve out from a much larger seller, it depends on a transition services agreement with Honeywell for a period after closing, and Brady has never absorbed anything close to this size. Financing adds a second layer, since the ~$1.6 billion of new debt includes ~$800 million of private placement senior notes at ~5.43 percent, ~5.65 percent and ~5.90 percent across 2031, 2033 and 2036 maturities, plus ~$800 million drawn under a floating rate credit agreement. PSS was also a business Honeywell chose to sell, and its ~$1.1 billion of 2025 revenue came with growth and margin characteristics outside investors cannot see the way they can see Brady's own segments. Demand is cyclical across electronics, manufacturing, construction and now logistics, and roughly a third of sales originate in Europe and Australia, so currency moves reported results both ways. One structural point: BRC is the nonvoting Class A share and all voting power sits with three holders of Class B stock, and Brady's fiscal 2025 annual report states it is not party to any material pending legal proceedings.

We give no verdict on Brady Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. The Honeywell carve out remakes the company. PSS sells mobile computers, barcode scanners, printing hardware and voice guidance software to large logistics, warehousing, manufacturing and retail customers from a base in Fort Mill, South Carolina.

The case against. The central risk is integration: PSS is a carve out from a much larger seller, it depends on a transition services agreement with Honeywell for a period after closing, and Brady has never absorbed anything close to this size.

Read the full bull and bear case on BRC, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Brady Corporation's investor relations page or your broker.

• Revenue (TTM): ~$1.62B
• Diluted EPS (TTM): ~$4.37
• Q3 FY2026 sales: ~$435M, up ~13.8% (organic ~8.2%)
• FY2026 adjusted EPS guidance: ~$5.20 to ~$5.30 (excludes PSS)
• Market cap: ~$4.41B (~21x trailing earnings)
• Acquisition debt raised: ~$1.6B, targeting ~2.5x net debt to EBITDA at close

Brady's fiscal year ends July 31, so the most recent reported period is the third quarter ended April 30, 2026, and full year fiscal 2026 results are due in early September 2026. That report matters more than usual because it should carry the first guidance including PSS, which closed on August 3, 2026 and therefore lands in fiscal 2027. Until then the trailing multiple near ~21 times and the forward multiple near ~15 times describe two different companies.

Other names that sit close to BRC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BRC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BRC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BRC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

A steady niche manufacturer with a 40 year record of dividend increases has just made the largest bet in its history, so the case for BRC now turns on integrating a business roughly two thirds its own size.

Whether BRC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BRC a buy or a sell?, and where the stock could go from here in the BRC stock forecast.

For income investors, whether BRC pays a dividend and how the payout looks is covered in does BRC pay a dividend? And to weigh BRC against a peer, read the full side-by-side comparisons: BRC vs AVY and BRC vs ZBRA.